Lockheed Martin Q1 2026 earnings miss on F-16, C-130 delays

Lockheed Martin's Q1 net earnings fell to $1.5 billion, or $6.44 per share, from $1.7 billion, or $7.28 per share, while free cash flow swung to negative $291 million from positive $955 million. Operating profit dropped 13% to $1.8 billion, pressured by $125 million in F-16 issues and $55 million in C-130 delivery delays; Aeronautics, Rotary and Mission Systems, and Space all saw profit declines. The company reiterated full-year 2026 sales of $77.5 billion to $80.0 billion and free cash flow of $6.5 billion to $6.8 billion despite rising inflation- and tariff-related cost pressure.

Analysis

The key issue is not a one-quarter miss; it is that Lockheed is showing classic late-cycle defense manufacturing stress: legacy platforms are becoming margin sinks precisely when the company is being asked to scale newer missile franchises faster. That creates a tension between near-term profitability and strategic relevance, because every incremental dollar of throughput on Patriot/THAAD/JASSM is being partially offset by cost leakage and rework in older aircraft and rotorcraft lines. In other words, growth is now being funded by operational slippage rather than clean operating leverage.

The cash flow inflection is the more important tell. Negative FCF with higher capex and working-capital drag suggests the company is entering a period where billing timing, supplier constraints, and inflation pressures can all stack in the same direction, making quarterly cash generation lumpy even if annual guidance stays intact. That matters because the stock typically trades like a quality compounder; repeated quarters of cash under-delivery can force multiple compression before analysts fully haircut the guidance range.

The second-order winner is the supply-chain ecosystem around missile components and energetics, not the primes themselves. If production is really moving toward 3-4x current rates, the bottleneck shifts to propellants, seekers, energetics, specialty castings, and electronic subassemblies, which should benefit select defense suppliers with pricing power and long-cycle government demand. Conversely, legacy aircraft suppliers tied to diminishing-manufacturing-source parts are likely to face harsher qualification friction and margin pressure, and that risk can persist for several quarters as inventory is reworked.

Consensus is probably underestimating how durable the backlog erosion can be if conversion quality keeps deteriorating. The headline backlog is still huge, but the mix matters: if the fastest-growing programs are also the least profitable, backlog is a weaker support for equity value than usual. Near term, the stock can still bounce on reaffirmed guidance, but the better setup is to fade strength until investors see at least one clean quarter of FCF recovery and fewer program-specific adjustments.

Key Decisions for Investors

• Short LMT on a 1-3 month horizon into any post-earnings strength; use a tight stop above the pre-earnings range high. Risk/reward favors downside if the market starts marking down FCF quality and margin durability rather than focusing on unchanged full-year guidance.
• Pair trade: long RTX or HWM vs short LMT for 3-6 months. Thesis: capital will rotate toward defense names with cleaner execution and better exposure to missile/systems growth, while LMT remains a cash-flow repair story.
• Buy call spreads on select defense suppliers tied to missile/energetics or electronic content for a 6-12 month horizon. The implied second-order beneficiary is the component layer, where incremental volume should translate more cleanly than at the prime level.
• If LMT sells off on guidance skepticism, cover into the first sign of working-capital normalization rather than waiting for margin improvement. The stock can re-rate quickly on one clean cash-flow quarter even if reported EPS stays noisy.